Insmed Incorporated
INSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11 | $4 | $2 | $3 |
| - Cash | $1 | $0 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $12 | $5 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.2% | 24.4% | 30.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.4% | 78.5% | 77.5% | 76.6% |
| EBITDA | -$1 | -$1 | -$0 | -$0 |
| % Margin | -225.1% | -216.3% | -182.3% | -203.6% |
| Net Income | -$1 | -$1 | -$0 | -$0 |
| % Margin | -251.2% | -245.6% | -196.3% | -230.6% |
| EPS Diluted | -5.57 | -5.34 | -3.91 | -3.88 |
| % Growth | -4.3% | -36.6% | -0.8% | – |
| Operating Cash Flow | -$1 | -$1 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$0 | -$0 |